Is Berkshire Hathaway Stock a Buy Right Now?

Greg Abel succeeds Warren Buffett as Berkshire Hathaway CEO after Buffett retired at the end of 2025; the company held $373 billion in cash at year-end. Berkshire shares are down ~4.2% year-to-date and ~8% over the past 12 months; Abel's first quarterly results/Q&A are due May 2 and he will preside over the upcoming shareholders' meeting. Management emphasizes continuity of culture and risk management, but the large cash stockpile raises the prospect of a meaningful deployment of capital under the new CEO, which could move BRK shares modestly.

Analysis

The management handoff increases optionality on capital deployment without necessarily changing the underlying competitive advantages of Berkshire’s operating businesses. Expect a bias toward diversified, structured deployments (preferreds, insurance-linked financings, minority stakes) rather than a single mega-acquisition; those instruments preserve downside while delivering mid-single-digit incremental returns that compound quietly across insurance float and industrial cashflows over 12–36 months.

A more active capital allocator will shift observable metrics before permanent returns: watch for stepped-up announced investments, an acceleration in opportunistic buybacks, or novel hybrid financings. Those moves will compress headline cash balances but should unlock EPS and book-value reversion within 6–18 months — however, competition from PE and sovereign buyers raises the prospect of paying up, which would dilute IRR even as activity signals competence.

Market structure and positioning create a short-term trading edge: flows into value and insurance proxies tend to accelerate when volatility rises and growth leadership stumbles; conversely, a renewed momentum leg in headline growth names could leave Berkshire looking defensive and underperforming for quarters. The immediate catalyst window is the next earnings/meeting cadence (days–weeks), while the substantive test of Abel-era allocation strategy plays out over quarters to years.

The consensus understates a governance vector: new CFO and operating leads create a binary outcome — either disciplined, instrumented deployment that ratchets shareholder returns, or legacy-establishing bolt-ons that deliver headline activity with subpar IRRs. That binary is asymmetric for investors: modest upside from patience but meaningful downside if acquisitions are value-destroying, making active sizing and event-focused entry essential.

Key Decisions for Investors

• Initiate a 2–4% portfolio position long BRK.B (ticker BRKB) on a 6–18 month horizon; scale in on any >5% pullback. Risk management: hard stop at -12% from entry or trim 50% on a >12% rally. R/R: 1.5–3x if management deploys capital at mid-single-digit incremental returns within 12 months.
• Pair trade: long BRKB / short SPY (equal notional) for 3–9 months to express a value-rotation thesis while hedging beta. Size at 1–2% net exposure; expected outperformance 4–8% if volatility and value flows reassert; downside is underperformance during a broad risk-on rally.
• Event-driven options: buy a 3-month BRKB call spread (buy near-ATM June calls, sell farther OTM Sep calls) sized to 0.5–1% of portfolio ahead of the earnings/meeting window. Rationale: asymmetric payoff to a capital-deployment announcement; maximum loss = premium, target >2x payoff if message and actions surprise positively.
• Tactical hedge if concerned about overpayment risk: reduce gross exposure and open a small long BRKB / short NVDA pair (0.5–1% notional) for 3–6 months — captures rotation from frothy growth into cash-rich, insurance-backed businesses. Risk: NVDA outperformance would pressure the pair; cap size to limit drawdown.